Neurosearch's Podcast Neurosearch

In today’s episode, Neurologist, Robert M. Hutchman, MD, MDS, discusses Depression in Parkinson’s disease. Some studies indicate that anywhere from 40% to 60% of PD suffers experience clinically significant depression. Several recent research efforts have examined the efficacy of treating depression in PD with medications that approach mood stabilization differently. Some recent research is discussed that indicates depression in the Parkinson’s disease may have a different pathology that requires a different treatment approach. Tricyclic Anti-depressants (TCA), Selective Serotonin Reuptake Inhibitors (SSRI), and a relatively new class of extended release atypical anti-depressants called norepinephrine and dopamine reuptake inhibitor (NDRI) are discussed in today’s episode. As Dr. Hutchman explains, the objective is to find the best medication to treat these complex issues. Does new medical research hold the answer to better treatments? Listen and find out.

In today’s episode, Neurologist, Robert M. Hutchman, MD, MDS, discusses Psychosis in Parkinson’s disease. Parkinson’s disease, which is a form of progressive paralysis, is due to the loss of a chemical neurotransmitter in the brain called dopamine. Psychosis, which is essentially audio or visual hallucinations or delusional thinking, is sometimes related to too much dopamine in the brain. As Parkinson’s disease progresses, some studies indicate that anywhere from 40% to 70% of PD suffers will develop Psychosis. Psychosis in PD has been a vexing problem to treat because the motor-based problems of Parkinson’s are best helped by inducing or protecting dopamine in the brain. Conversely, Psychosis can be related to that same dopaminergic therapy. Add to this that most medications currently available for the treatment of Psychosis simply do not work well. As Dr. Hutchman explains, the objective is to find balance in treating these complex issues. Does new medical research hold the answer to better treatments? Listen and find out.

In today’s episode, Neurologist, Robert Shorr, MD, discusses Epilepsy with the eminent Pediatric Neurologist and Epilepsy Specialist, William Goldie, MD. Dr. Goldie, who received his training at Stanford, UC Berkley, and Johns Hopkins Hospital, is a former Chief of Pediatric Neurology at Children’s Hospital in Los Angeles, and is the current head of Pediatric Neurology at Ventura County Medical Center. Today’s topic is an expansion of our previous Parkinson’s disease focused episodes to include other neurodegenerative indications. Interestingly, some newer medications are currently being researched for concurrent benefits in both Parkinson’s populations and Epilepsy populations. Although Epilepsy generally first manifests symptoms in childhood, this condition can continue through adolescence into adulthood and can be very difficult to manage. Seizure disorders in the very young and in elderly populations are the most dramatic and complex to manage. In today’s show, Dr. Shorr and Dr. Goldie discuss the pathology of Epilepsy and review emerging treatments. We are delighted to bring you this fascinating overview of Epilepsy.

In today’s episode, Neurologist, Robert Shorr, MD, discusses Parkinson’s disease dementia with host Tom Spence, of Ventura radio station KKZZ, 1400 AM. Several leading studies indicate that dementia afflicts over 40% of patients with Parkinson’s disease. Dementia has a tremendous impact on families and caregivers of Parkinson’s patients and is a leading factor for entry into skilled care facilities. In today’s show, Dr. Shorr discusses the pathology of dementia and reviews emerging treatments.

In today’s episode of the “Dr. Rob and Dr. Bob Show”, Co-hosts Tom Spence, of Ventura radio station KKZZ, 1400 AM and Susan Kline, Executive Director of the Hazel Hutchman Memorial Neuroscience Center, interview a panel of patients discussing Young Onset Parkinson’s disease. Parkinson’s disease is commonly associated with persons who are over the age of 60. However, Parkinson’s can afflict patients as young as two years of age. Young onset PD, is found in approximately 15% of Parkinson’s patients. Notable celebrity and Parkinson’s disease research activist, Michael J. Fox, has promoted greater awareness of young onset PD. In today’s show, the guest panel includes three locally distinguished Early Onset Parkinson’s patients, Pete Howard, John Evarone, and Rod Preston.

In today’s episode, John Ball, marathon runner, author of “Living Well, Running Hard: Lessons Learned from Living with Parkinson’s disease”, and the co-founder of TEAM PARKINSON’S, is interviewed by Susan Kline, Executive Director of the Hazel Hutchman Memorial Neuroscience Center, and Tom Spence of Ventura radio station KKZZ (1400 AM). John Ball is a pilot, marathon runner, author, and a leading Parkinson’s disease research advocate having raised over a million dollars for clinical research through TEAM PARKINSON’S since its founding in 2000. His book, which portrays his own intimate struggle with PD, has inspired thousand with Parkinson’s disease to fight their own battles with courage, determination, and joy! Listen as the excitement and energy in today’s episode motivates radio show host Tom Spence to join the fight and run in the LA Marathon. We are delighted to bring you this wonderful and uplifting episode.